NK cell compartment in the peripheral blood and spleen in adult patients with primary immune thrombocytopenia

Clinical Immunology

Volumn 177, Issue , 2017, Pages 18-28

  Ebbo, M ^a   Audonnet, S ^a   Grados, A ^a   Benarous, L ^a   Mahevas, M ^c   Godeau, B ^c   Viallard, J F ^b   Piperoglou, C ^a   Cognet, C ^a   Farnarier, C ^a   Harle J R ^a   Schleinitz, N ^a   Vely F ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ALPHA; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2C; NATURAL KILLER CELL RECEPTOR NKG2D; UNCLASSIFIED DRUG; IMMUNOLOGIC FACTOR;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DEGRANULATION; FEMALE; GENE EXPRESSION; HELPER CELL; HUMAN; HUMAN CELL; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOMODULATION; IMMUNOPHENOTYPING; INTERFERON PRODUCTION; MALE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SPLEEN; TARGET CELL; AGED; ANIMAL; BLOOD; CELL CULTURE; CONTROLLED CLINICAL TRIAL; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; K-562 CELL LINE; MIDDLE AGED; MONONUCLEAR CELL; MOUSE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TUMOR CELL LINE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; K562 CELLS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SPLEEN; YOUNG ADULT;

EID: 84949294514     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2015.11.005     Document Type: Article

References (31)

1. Zhao, C., Li, X., Zhang, F., Wang, L., Peng, J., Hou, M., Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies. Haematologica 93:9 (Sep 2008), 1428–1430.
2. Zhang, F., Chu, X., Wang, L., Zhu, Y., Li, L., Ma, D., et al. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. Eur. J. Haematol. 76:5 (2006 May), 427–431.
3. Olsson, B., Andersson, P.-O., Jernås, M., Jacobsson, S., Carlsson, B., Carlsson, L.M.S., et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat. Med. 9:9 (Sep 2003), 1123–1124.
4. Ji, L., Zhan, Y., Hua, F., Li, F., Zou, S., Wang, W., et al. The ratio of Treg/Th17 cells correlates with the disease activity of primary immune thrombocytopenia. PLoS One, 7(12), 2012, e50909.
5. Sehgal, K., Guo, X., Koduru, S., Shah, A., Lin, A., Yan, X., et al. Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia. Sci. Transl. Med., 5(193), Jul 10 2013, 193ra89.
6. McMillan, R., Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin. Hematol. 37:3 (Jul 2000), 239–248.
7. Bell, W.R., Role of splenectomy in immune (idiopathic) thrombocytopenic purpura. Blood Rev. 16:1 (2002 Mar), 39–41.
8. Kurata, Y., Curd, J.G., Tamerius, J.D., McMillan, R., Platelet-associated complement in chronic ITP. Br. J. Haematol. 60:4 (1985 Aug), 723–733.
9. Tomasello, E., Yessaad, N., Gregoire, E., Hudspeth, K., Luci, C., Mavilio, D., et al. Mapping of NKp46(+) cells in healthy human lymphoid and non-lymphoid tissues. Front. Immunol., 3, 2012, 344.
10. Soubrane, C., Tourani, J.M., Andrieu, J.M., Visonneau, S., Beldjord, K., Israel-Biet, D., et al. Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patient. Blood 81:1 (Jan 1 1993), 15–19.
11. Podolanczuk, A., Lazarus, A.H., Crow, A.R., Grossbard, E., Bussel, J.B., Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk. Blood 113:14 (Apr 2 2009), 3154–3160.
12. Vivier, E., Tomasello, E., Baratin, M., Walzer, T., Ugolini, S., Functions of natural killer cells. Nat. Immunol. 9:5 (May 2008), 503–510.
13. Schleinitz, N., Vély, F., Harlé, J.R., Vivier, E., Natural killer cells in human autoimmune diseases. Immunology 131:4 (Dec 2010), 451–458.
14. − natural killer cells subset. Blood 82:5 (Sep 1 1993), 1538–1545.
15. Semple, J.W., Bruce, S., Freedman, J., Suppressed natural killer cell activity in patients with chronic autoimmune thrombocytopenic purpura. Am. J. Hematol. 37:4 (Aug 1991), 258–262.
16. Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D.M., et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113:11 (Mar 12 2009), 2386–2393.
17. Schleinitz, N., Chiche, L., Guia, S., Bouvier, G., Vernier, J., Morice, A., et al. Pattern of DAP12 expression in leukocytes from both healthy and systemic lupus erythematosus patients. Zimmer J, editor. PLoS One, 4(7), 2009, e6264.
18. Talaat, R.M., Elmaghraby, A.M., Barakat, S.S., El-Shahat, M., Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP). Clin. Exp. Immunol. 176:2 (May 2014), 291–300.
19. + NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107:9 (May 1 2006), 3624–3631.
20. Morandi, B., Bougras, G., Muller, W.A., Ferlazzo, G., Münz, C., NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. Eur. J. Immunol. 36:9 (Sep 2006), 2394–2400.
21. Michael, A., Hackett, J.J., Bennett, M., Kumar, V., Yuan, D., Regulation of B lymphocytes by natural killer cells. Role of IFN-gamma. J. Immunol. 142:4 (Feb 15 1989), 1095–1101.
22. Krebs, P., Barnes, M.J., Lampe, K., Whitley, K., Bahjat, K.S., Beutler, B., et al. NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. Blood 113:26 (Jun 25 2009), 6593–6602.
23. Shi, F.D., Takeda, K., Akira, S., Sarvetnick, N., Ljunggren, H.G., IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J. Immunol. 165:6 (Sep 15 2000), 3099–3104.
24. Neunert, C., Lim, W., Crowther, M., Cohen, A., Solberg, L., Crowther, M.A., et al., The American Society of Hematology, Evidence-based practice guideline for immune thrombocytopenia. Blood 2011 (2011), 4190–4207.
25. Ferlazzo, G., Thomas, D., Lin, S.-L., Goodman, K., Morandi, B., Muller, W.A., et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 172:3 (Feb 1 2004), 1455–1462.
26. Grégoire, C., Chasson, L., Luci, C., Tomasello, E., Geissmann, F., Vivier, E., et al. The trafficking of natural killer cells. Immunol. Rev. 220 (Dec 2007), 169–182.
27. Lanier, L.L., Ruitenberg, J.J., Phillips, J.H., Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J. Immunol. 141:10 (Nov 15 1988), 3478–3485.
28. Erkeller-Yüsel, F., Hulstaart, F., Hannet, I., Isenberg, D., Lydyard, P., Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus 2:4 (Aug 1993), 227–231.
29. Jacobi, C., Claus, M., Wildemann, B., Wingert, S., Korporal, M., Römisch, J., et al. Exposure of NK cells to intravenous immunoglobulin induces IFN gamma release and degranulation but inhibits their cytotoxic activity. Clin. Immunol. 133:3 (Dec 2009), 393–401.
30. Bayry, J., Lacroix-Desmazes, S., Carbonneil, C., Misra, N., Donkova, V., Pashov, A., et al. Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood 101:2 (Jan 15 2003), 758–765.
31. Tha-In, T., Metselaar, H.J., Tilanus, H.W., Groothuismink, Z.M.A., Kuipers, E.J., de Man, R.A., et al. Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells. Blood 110:9 (Nov 1 2007), 3253–3262.